REstoration of COronary flow in patients with no-reflow after primary coronary interVEntion of acute myocaRdial infarction (RECOVER)

American Heart Journal

Volumn 164, Issue 3, 2012, Pages 394-401

  Huang, Dong ^a   Qian, Juying ^a   Ge, Lei ^a   Jin, Xuejuan ^a   Jin, Huigen ^b   Ma, Jianying ^a   Liu, Zongjun ^b   Zhang, Feng ^a   Dong, Lili ^a   Wang, Xiangfei ^a   Yao, Kang ^a   Ge, Junbo ^a  

^a FUDAN UNIVERSITY   (China)

^b Putuo District Center Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; DILTIAZEM; GLYCERYL TRINITRATE; TROPONIN T; VERAPAMIL;

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; BLOOD CLOT LYSIS; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG SAFETY; FEMALE; HEART RATE; HEART RHYTHM; HUMAN; INTRACORONARY INFUSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NO REFLOW PHENOMENON; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINUS BRADYCARDIA; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTOLIC BLOOD PRESSURE;

AGED; CORONARY CIRCULATION; DILTIAZEM; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; NITROGLYCERIN; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TROPONIN T; VASODILATOR AGENTS; VERAPAMIL;

EID: 84866317172     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.06.015     Document Type: Article

References (23)

1. A. Abbate, M.C. Kontos, and G.G. Biondi-Zoccai No-reflow: the next challenge in treatment of ST-elevation acute myocardial infarction Eur Heart J 29 2008 1795 1797
2. D. Brosh, A.R. Assali, and A. Mager Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality Am J Cardiol 99 2007 442 445 (Pubitemid 46223482)
3. B.M. Kaplan, K.H. Benzuly, and J.W. Kinn Treatment of no-reflow in degenerated saphenous vein graft interventions: comparison of intracoronary verapamil and nitroglycerin Cathet Cardiovasc Diagn 39 1996 113 118
4. A.D. Michaels, M. Appleby, and M.H. Otten Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no reflow (VAPOR) trial J Invasive Cardiol 14 2002 299 302 (Pubitemid 34651235)
5. G.S. Werner, K. Lang, and H. Kuehnert Intracoronary verapamil for reversal of no-reflow during coronary angioplasty for acute myocardial infarction Catheter Cardiovasc Interv 57 2002 444 451 (Pubitemid 35424121)
6. R.N. Piana, G.Y. Paik, and M. Moscucci Incidence and treatment of no-reflow after percutaneous coronary intervention Circulation 89 1994 2514 2518 (Pubitemid 24173664)
7. E.M. Antman, D.T. Anbe, and P.W. Armstrong ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction) J Am Coll Cardiol 44 2004 e1 e211
8. S.C. Smith Jr., T.E. Feldman, and J.W. Hirshfeld Jr. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention) J Am Coll Cardiol 47 2006 e1 e121
9. The TIMI Study Group The Thrombolysis in Myocardial Infarction (TIMI) trial N Engl J Med 312 1985 932 936
10. C.M. Gibson, C.P. Cannon, and W.L. Daley TIMI frame count: a quantitative method of assessing coronary artery flow Circulation 93 1996 879 888 (Pubitemid 26074824)
11. C.M. Gibson, S.A. Murphy, and M.J. Rizzo Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group Circulation 99 1999 1945 1950 (Pubitemid 29183889)
12. J.A. de Lemos, and E. Braunwald ST-segment resolution as a tool for assessing the efficacy of reperfusion therapy J Am Coll Cardiol 38 2001 1283 1294 (Pubitemid 33032999)
13. G. Ndrepepa, K. Tiroch, and M. Fusaro Five-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction J Am Coll Cardiol 55 2010 2383 2389
14. T. Svilaas, P.J. Vlaar, and I.C. van der Horst Thrombus aspiration during primary percutaneous coronary intervention N Engl J Med 358 2008 557 567 (Pubitemid 351214283)
15. M. Marzilli, E. Orsini, and P. Marraccini Beneficial effects of intracoronary adenosine as adjunct to primary angioplasty in acute myocardial infarction Circulation 101 2000 2154 2159 (Pubitemid 30253043)
16. J.A. de Lemos, E.M. Antman, and C.M. Gibson Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial Circulation 101 2000 239 243 (Pubitemid 30054149)
17. C. Barcin, A.E. Denktas, and R.J. Lennon Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no-reflow phenomenon Catheter Cardiovasc Interv 61 2004 484 491 (Pubitemid 38419135)
18. W.B. Hillegass, N.A. Dean, and L. Liao Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience J Am Coll Cardiol 37 2001 1335 1343
19. M.D. Fugit, B.J. Rubal, and D.J. Donovan Effects of intracoronary nicardipine, diltiazem and verapamil on coronary blood flow J Invasive Cardiol 12 2000 80 85
20. F.J. Weyrens, J. Mooney, and J. Lesser Intracoronary diltiazem for microvascular spasm after interventional therapy Am J Cardiol 75 1995 849 850
21. J.P. Henriques, F. Zijlstra, and A.W. van't Hof Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade Circulation 107 2003 2115 2119 (Pubitemid 36532193)
22. S.D. Roes, S. Kelle, and T.A. Kaandorp Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction Am J Cardiol 100 2007 930 936 (Pubitemid 47368098)
23. E. Wu, J.T. Ortiz, and P. Tejedor Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study Heart 94 2008 730 736 (Pubitemid 351744690)